Prednisolone Induced Systemic Toxicity in Case of Steroid Sensitive Nephrotic Syndrome

Published on:August 2021
Indian Journal of Pharmacy Practice, 2021; 14(3):230-232
Case Report | doi:10.5530/ijopp.14.3.47

Prednisolone Induced Systemic Toxicity in Case of Steroid Sensitive Nephrotic Syndrome

Authors and affiliation (s):

Nishi Sheth*, Dhruv Zaveri, Hemraj Singh Rajput

Department of Pharmacy, Sumandeep Vidyapeeth (Deemed to be University), Piparia, Waghodia, Vadodara, Gujarat, INDIA.


Prednisolone is a corticosteroid, it works on immune system to relieve swelling, redness, and is a choice of drug for arthritis, cancer, asthma, allergic condition, bell’s palsy, Nephrotic syndrome and disorders of endocrine system. Prednisolone helps decreasing inflammation by suppression of leukocytes and decrease expression of pro-inflammatory markers. Nephrotic syndrome is a condition in which damage kidney glomeruli which leaks protein into urine from blood. In pediatric population the choice of drug selected is prednisolone which resolves the symptoms and reduces infection. Prednisolone is the drug considered for the frequently relapsing Nephrotic syndrome. It should be given on alternate basis. for patient with infrequent relapses, therapy should be not prolonged. Adverse effects of prednisolone are hypertension, adrenal suppression, osteoporosis, diabetes mellitus, poor growth and cushingoid syndrome. Systemic toxicity due to prednisolone in pediatric patient increases the risk of infection and pre-renal failure. In this case report, it is summarized that despite of everyday prednisolone intake, alternate day therapy is more effective and causes less side effects. Proper monitoring is necessary and timely laboratory findings should be obtained for less adverse events.

Key words: Prednisolone, Toxicity, Nephrotic syndrome, Adverse drug reaction, Pre-renal failure.


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs